<div>
  <p>
  </p>
  <ul>
    <li>
      <p>
        Rezilient Health raised USD 10 million in Series A funding led by Govo Venture Partners, with participation from Bridge Ventures, Acorn Pacific Ventures, The Council, and other investors.
      </p>
    </li>
    <li>
      <p>
        The new funds will support the expansion of the company's service offerings, further development of its CloudClinic model, and the opening of more CloudClinic locations in Missouri, Texas, and Oklahoma. Rezilient also plans to expand its scope of services and enhance its technology platform.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://hitconsultant.net/2024/10/03/rezilient-health-cloudclinics-funding/">
      Hit Consultant
    </a>
  </p>
  <p>
    <a href="https://www.finsmes.com/2024/10/rezilient-health-raises-10m-in-series-a-funding.html">
      FinSMEs
    </a>
     
  </p>
</div>


Preventive Healthcare

<div>

<p>Rezilient Health has secured USD 10 million in Series A funding. The round was led by Govo Venture Partners and saw participation from Bridge Ventures, Acorn Pacific Ventures, The Council, among others.</p>
<p>The latest investment will aid in the growth of the company's services, development of its CloudClinic model and enable it to open additional CloudClinic locations in Missouri, Texas, and Oklahoma. Furthermore, the company is looking to broaden its services and elevate its technology platform.</p>

</div>

Rezilient Health raises USD 10 million in Series A funding to expand CloudClinics

<div>
 
 <p>BioIntelliSense, a provider of remote patient monitoring, has obtained FDA clearance for its BioButton Multi-Patient wearable and BioDashboard system for continuous patient monitoring. This technology is intended to automate the gathering of vital signs in diverse hospital settings like medical-surgical units, specialty care sectors, and emergency departments, as well as provide hospital-quality care at home.</p>
 <p>The BioButton Multi-Patient wearable broadens BioIntelliSense's range of continuous patient monitoring solutions. The innovative BioDashboard clinical intelligence system offers scalable, automated trending notifications tailor-made for each patient. This capability enables a single clinician to monitor hundreds of BioButton patients at the same time.</p>
 
</div>

BioIntelliSense receives FDA clearance for BioButton Multi-Patient wearable and BioDashboard system

ANALYST_QUICK_TAKE

PROMINENT_CATEGORY

<div>
 
 <p>DarioHealth, a digital therapeutics (DTx) platform, is partnering with a national Medicare Advantage health plan to offer digital mental health benefits via its Twill by Dario platform. This contract, DarioHealth's fourth with a national health plan and its first in the Medicare Advantage market, could potentially lead to further expansion with Dario solutions in 2026.</p>
 <p>The agreement is scheduled to begin in January 2025 and will provide behavioral health solutions specifically designed for seniors. The objective of the partnership is to promote healthy aging by addressing emotional health, well-being, and social determinants of health through the use of AI-based network navigation and digital Cognitive Behavioral Therapy programs.</p>
 
</div> <p><b>Analyst QuickTake</b> :<br>
 The behavioral health solution was integrated into DarioHealth’s cardiometabolic platform following the acquisition of Twill in <a href="https:<br>
//sp-edge.com/updates/26857"> February 2024 </a> . The acquisition aimed to widen its customer base, enhance operational efficiency, and accelerate profitability.</p>

DarioHealth partners with Medicare Advantage plan to offer behavioral health solutions

INCUMBENTS_PRESENT

<div>
 
 <p>CVS Health is planning to lay off 2,900 employees. This amounts to roughly 1% of their total 300,000-person workforce. This is part of a USD 2 billion cost-cutting plan that was announced this summer. The move comes in response to rumors of a potential strategic review, which could include a breakup of its businesses.</p>
 <p>The layoffs are mainly going to affect corporate positions. Frontline workers in CVS stores or pharmacies will not be hit by this move. The company has stated that the reduction in workforce is a response to ongoing disruption, regulatory pressures, and a shift in consumer needs.</p>
 
</div>

CVS to lay off 2,900 employees as part of cost-cutting strategy

<div>
 
 <p>Wellinks, a company offering virtual management solutions for chronic obstructive pulmonary disease (COPD), has taken over Spire Health, a firm renowned for its continuous respiratory monitoring capabilities. The details of this non-cash transaction have not been revealed.</p>
 <p>With this acquisition, Wellinks plans to incorporate Spire's patient monitoring technology in its virtual-led care model, which will lead to the establishment of a comprehensive Predictive Patient Care enterprise. This amalgamation positions Wellinks to provide innovative solutions to payors and providers in managing COPD and congestive heart failure patients. It aims to leverage patient data, predictive analytics, and specialized treatment pathways for effective patient management.</p>
 
</div>

Wellinks acquires Spire Health to enhance cardiopulmonary care

<div>
 
 <p>Orpyx Medical Technologies, a company focusing on the prevention of diabetic foot ulcers, has received $20 million in growth funding from Perceptive Advisors. The additional funds will help speed up commercial efforts to provide solutions for patients and healthcare providers. The aim is to improve outcomes for those at risk of complications from diabetic foot ailments.</p> 
 <p>The Sensory Insole system developed by Orpyx enhances custom orthotics with multi-modal sensor technology. This allows for continuous remote monitoring of plantar pressure, temperature, and activity, as well as adherence to the program. Partnerships with health plans and organizations such as the Veterans Health Administration help in the prevention efforts for diabetic foot ulcers and related amputations. </p>
 <p><b>Analyst QuickTake: </b> Diabetic foot ulcer is a preventable health issue common to diabetes patients and can lead to amputations if not treated. In the US, about 130,000 diabetes-related amputations are carried out each year. Podimetrics, MR3Health, and Siren Care are other companies working on solutions for diabetic foot ulcer detection.</p>
 
</div>

Orpyx raises USD 20 million in growth funding to accelerate commercialization of solutions

<div>
 <p>Midi Health, a healthcare provider focusing on women's midlife health, has secured an additional USD 5 million in funding through a special purpose vehicle (SPV) managed by venture fund Operator Collective. This SPV has support from a distinguished set of female leaders from varied fields, such as comedian Amy Schumer, actress Connie Britton, soccer icon Brandi Chastain, activist and attorney Meena Harris, business executive Sheryl Sandberg, Waymo co-CEO Tekedra Mawakana, and fashion designer Tory Burch.</p>
 <p>The newly acquired funds will be channeled towards expanding its operations and accomplishing its mandate of bridging the women's healthcare gap.&nbsp;</p>
 
</div> <p><b>Analyst QuickTake</b> :<br>
 This notable group of women leaders joins other Series B investors from an <a href="https:<br>
//sp-edge.com/updates/28785"> April 2024 </a> round, including Emerson Collective, Google Ventures, Memorial Hermann, SemperVirens, Felicis, Icon Ventures, Black Angel Group, and Gingerbread Capital. This underscores the company’s commitment to delivering expert and insurance-friendly healthcare to women in perimenopause and menopause stages.</p>

Midi Health raises additional USD 5 million in Series B funding via SPV to expand operations

<div>
 <p>Alex Therapeutics, a digital health provider, is partnering with Navamedic, a pharmaceutical company from Sweden, to create a companion app specifically designed to manage Parkinson's disease treatment. </p>
 <p>This application will offer patients who are taking Flexilev, a prescription medication for Parkinson's, assistance in managing their medication. This will augment the function of the OraFID dose dispenser, creating a unique combination to promote adherence to personalized treatment schedules. With its initial launch in Sweden, Norway, and Denmark planned within the next year, there are also plans for this app to be expanded globally in future.</p>

</div> <p><b>Analyst QuickTake:<br>
 </b> In <a href="https:<br>
//www.prnewswire.com/news-releases/pfizer-and-alex-therapeutics-announce-a-strategic-commercial-partnership-to-provide-evidence-based-digital-therapeutics-to-patients-starting-in-germany-301471350.html"> January 2022 </a> , the company partnered with Pfizer to develop a digital therapeutics (DTx) app to treat nicotine addiction. The company had also partnered with Vicore Pharma to develop a DTx for treating anxiety and depression in patients with idiopathic pulmonary fibrosis.</p>

Alex Therapeutics partners with Navamedic to develop Parkinson's disease companion app

<div>
 
 <p>The digital health company, Hinge Health, has launched Enso 3, an FDA-cleared device for pain relief. This wireless device employs electrical nerve stimulation as a non-invasive, non-addictive method for pain relief. Accessibility for new Hinge Health members will commence in 2025.</p>
 <p>New hardware with improved aesthetics and materials are featured in Enso 3, making it comfortable to wear during exercise or daily activities. The device offers new electric waveforms that are clinically proven and custom-made for various body parts and pain levels. It also has the capacity for future waveform releases through over-the-air software updates. Enso 3 is integrated with the Hinge Health app for member guidance and tracking progress. </p>
 
</div> <p><b>Analyst Quicktake:<br>
 </b> Hinge Health acquired Enso in <a href="https:<br>
//sp-edge.com/updates/2441"> March 2021 </a> for an undisclosed sum. At the time, Hinge Health intended to offer Enso’s device, together with Hinge’s digital musculoskeletal (MSK) solutions, to employers and health plans as an alternative to opioid pain medication.</p>

Hinge Health launches Enso 3 for musculoskeletal pain relief

<div>
 <p>Viome Life Sciences, a startup specializing in passive remote monitoring, has successfully secured USD 25 million in a Series D funding round. Key participants included prominent entities such as Khosla Ventures, Bold Capital, WRG Ventures, and Marc Benioff among others.</p>
 <p>This newly raised capital is intended to be allocated for the inception of a diagnostics division as well as the expansion of current solutions aimed at chronic diseases, cancer, and aging. As part of this strategic development, the company has welcomed Kal Raman to its executive team in the role of chief operating officer (COO). Boasting a diverse professional background, Raman has held notable positions at esteemed organizations such as Samsung, Groupon, and Amazon, where he worked under the direct leadership of Jeff Bezos.</p>
</div>

All Updates

Rezilient Health raises USD 10 million in Series A funding to expand CloudClinics

BioIntelliSense receives FDA clearance for BioButton Multi-Patient wearable and BioDashboard system

DarioHealth partners with Medicare Advantage plan to offer behavioral health solutions

CVS to lay off 2,900 employees as part of cost-cutting strategy

Wellinks acquires Spire Health to enhance cardiopulmonary care

Orpyx raises USD 20 million in growth funding to accelerate commercialization of solutions

Midi Health raises additional USD 5 million in Series B funding via SPV to expand operations

Alex Therapeutics partners with Navamedic to develop Parkinson's disease companion app

Hinge Health launches Enso 3 for musculoskeletal pain relief

Viome raises USD 25 million in Series D funding to launch diagnostics division; appoints new COO

Preventive Healthcare

Rezilient Health raises USD 10 million in Series A funding to expand CloudClinics

Contact us